Skip to main content
. 2015 Jan 1;1(1):17–22. doi: 10.1016/S2055-6640(20)31149-3

Table 1.

Summary of the major ART–additive intervention studies in non–human primates aimed at understanding and/or impacting HIV latency, immune function and eradication

Reference NHP species Virus Additive intervention Duration of ART (months) Main effects
Klatt et al. [35] Pig–tail macaques SIVmac 239 Administration of probiotics/prebiotics 5 Improved reconstitution of intestinal CD4 T cells and lower frequency of those expressing Ki-67
Micci et al. [16] Rhesus macaques SIVmac 239 Administration of interleukin–(21) 7 Reconstitution of intestinal Th17 cells and reduction of systemic and intestinal residual inflammation; reduced cell–associated SIV-DNA in the GI tract during ART
Improved control of immune activation, viral replication, and CD4 homeostasis following ART interruption
Mason [37] Rhesus macaques SIVmac 251 Administration of anti–PD–L1 10 Viral rebound delay following ART-interruption in four out of eight animals
Del Prete et al. [19] Rhesus macaques SIVmac 239 Administration of SAHA up to 12 Increased histone acetylation and cell-associated SIV–vRNA:vDNA ratio post-SAHA administration
Mavigner et al. [58] Rhesus macaques RT–SHIV TC Autologous haematopoietic stem cell transplant post total body irradiation up to 4 Rapid viral rebound post-ART interruption despite successful HSCT in two out of three animals